Schizophrenia and the gut–brain axis (Q22251211)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

1 reference

title

Schizophrenia and the gut-brain axis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

0 references

2

Reza Hosseini Ghomi

Reza

Hosseini Ghomi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Katlyn Nemani

1

Katlyn

Nemani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Beth McCormick

series ordinal

3

author given names

Beth

author last names

McCormick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Xiaoduo Fan

series ordinal

4

author given names

Xiaoduo

author last names

Fan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

19 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

number of pages

6

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

inferred from page(s)

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

155-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Effect of intestinal microbial ecology on the developing brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Specific IgA antibody increases in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Pyrosequencing study of fecal microflora of autistic and control children

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Genetic insight of schizophrenia: past and future perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Coordination of tolerogenic immune responses by the commensal microbiota

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Major depressive disorder: probiotics may be an adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Increased annexin-V and decreased TNF-α serum levels in chronic-medicated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Th1, Th2 and Th3 cytokine alteration in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Activation of Th17 cells in drug naïve, first episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Subunit and whole molecule specificity of the anti-bovine casein immune response in recent onset psychosis and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Association between bovine casein antibody and new onset schizophrenia among US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Gastrointestinal inflammation and associated immune activation in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

1 reference

7 January 2021

Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

A core gut microbiome in obese and lean twins

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Common variants conferring risk of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Microbes in gastrointestinal health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Therapeutic potential of fecal microbiota transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The gut microbiota as an environmental factor that regulates fat storage

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Normal gut microbiota modulates brain development and behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Wheat "consumption" and hospital admissions for schizophrenia during World War II. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

A study of circulating gliadin antibodies in schizophrenia among a Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Toxoplasma gondii and other risk factors for schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

NMDA receptor and schizophrenia: a brief history

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The new link between gut-brain axis and neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Food allergy: a glimpse into the inner workings of gut immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The microbiome-gut-brain axis: from bowel to behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The gluten connection: the association between schizophrenia and celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Autoimmune diseases and infections as risk factors for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Microbial exposure during early life has persistent effects on natural killer T cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Wheat Gluten as a Pathogenic Factor in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Relapsed Schizophrenics: Earlier Discharge from the Hospital After Cereal-Free, Milk-Free Diet

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Diet, microbiota and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Gastrointestinal flora and gastrointestinal status in children with autism – comparisons to typical children and correlation with autism severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Factors influencing the composition of the intestinal microbiota in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Inflammation and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Small intestinal inflammation following oral infection with Toxoplasma gondii does not occur exclusively in C57BL/6 mice: review of 70 reports from the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Evidence for an immune role on cognition in schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Elevated gliadin antibody levels in individuals with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Microbial-induced Th17: superhero or supervillain?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora

1 reference

https://api.crossref.org/works/10.1016%2FJ.PNPBP.2014.08.018

7 January 2021

10.1016/J.PNPBP.2014.08.018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25240858%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017